Skip navigation

Chemical Ergocalciferols

1–33 of 33 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 1,25-dihydroxyergocalciferol positive regulation of myeloid leukocyte differentiation 1,25-dihydroxyergocalciferol results in increased positive regulation of myeloid leukocyte differentiation 1: Homo sapiens Myeloid Progenitor Cells | Cell Line, Tumor   1
2. 1,25-dihydroxyergocalciferol drug metabolic process Ketoconazole [Ketoconazole results in decreased drug metabolic process] which results in decreased chemical synthesis of 1,25-dihydroxyergocalciferol 1: Homo sapiens Keratinocytes | Cell Line   1
3. 17,20-dihydroxyvitamin D2 drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased chemical synthesis of 17,20-dihydroxyvitamin D2 1: Homo sapiens Placenta | Mitochondria   1
4. 17,20-dihydroxyvitamin D2 drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased chemical synthesis of 17,20-dihydroxyvitamin D2 1: Bos taurus Adrenal Cortex | Mitochondria   1
5. 1 alpha-hydroxyergocalciferol drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 1 alpha-hydroxyergocalciferol 1: Homo sapiens Placenta | Mitochondria 1 gene: CYP3A4 1
6. 1 alpha-hydroxyergocalciferol drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 1 alpha-hydroxyergocalciferol 1: Bos taurus Adrenal Cortex | Mitochondria 1 gene: CYP3A4 1
7. 20-hydroxyvitamin D2 drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 20-hydroxyvitamin D2 1: Bos taurus Adrenal Cortex | Mitochondria   1
8. 20-hydroxyvitamin D2 drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased hydroxylation of 20-hydroxyvitamin D2 1: Homo sapiens Placenta | Mitochondria   1
9. 24a-homo-1,15-dihydroxyergocalciferol positive regulation of myeloid leukocyte differentiation 24a-homo-1,15-dihydroxyergocalciferol results in increased positive regulation of myeloid leukocyte differentiation 1: Homo sapiens Myeloid Progenitor Cells | Cell Line, Tumor   1
10. paricalcitol cell differentiation paricalcitol results in increased cell differentiation 1: Homo sapiens U937 Cells
6 genes: BMP4 | COL15A1 | FRZB | MGP | SPP1 | TNFSF11
1
11. paricalcitol monocyte differentiation paricalcitol results in increased monocyte differentiation 1: Homo sapiens U937 Cells
2 genes: BMP4 | PPARG
1
12. paricalcitol cell differentiation paricalcitol results in increased cell differentiation 1: Homo sapiens HL-60 Cells
6 genes: BMP4 | COL15A1 | FRZB | MGP | SPP1 | TNFSF11
1
13. paricalcitol cholesterol homeostasis paricalcitol affects cholesterol homeostasis 1: Mus musculus Plasma
2 genes: APOE | NCOR1
1
14. paricalcitol cell cycle paricalcitol results in decreased cell cycle 1: Homo sapiens HL-60 Cells 1 gene: MAPK13 1
15. paricalcitol cell cycle paricalcitol results in decreased cell cycle 1: Homo sapiens U937 Cells 1 gene: MAPK13 1
16. paricalcitol monocyte differentiation arsenic trioxide arsenic trioxide promotes the reaction [paricalcitol results in increased monocyte differentiation] 1: Homo sapiens U937 Cells
2 genes: BMP4 | PPARG
1
17. paricalcitol cell proliferation paricalcitol results in decreased cell proliferation 1: Homo sapiens HL-60 Cells
9 genes: BCL2 | BCL2L1 | BMP4 | CRIP1 | IL1A | ITGA2 | NPY | TGFB1 | TNF
1
18. paricalcitol apoptotic process arsenic trioxide [paricalcitol co-treated with arsenic trioxide] results in increased apoptotic process 1: Homo sapiens Bone Marrow | Myeloid Cells | Cell Line, Tumor
11 genes: BCL2 | BCL2A1A | BCL2L1 | CD14 | IL1A | IL1B | IL24 | NR4A1 | PRKCA | TNF | TNFRSF11B
1
19. paricalcitol cell proliferation paricalcitol analog results in decreased cell proliferation 1: Homo sapiens Prostate | Cell Line, Tumor
9 genes: BCL2 | BCL2L1 | BMP4 | CRIP1 | IL1A | ITGA2 | NPY | TGFB1 | TNF
1
20. paricalcitol cholesterol homeostasis Cholesterol [paricalcitol affects cholesterol homeostasis] which results in increased abundance of Cholesterol 1: Mus musculus Plasma
2 genes: APOE | NCOR1
1
21. paricalcitol cholesterol homeostasis Cholesterol [paricalcitol affects cholesterol homeostasis] which results in decreased abundance of Cholesterol 1: Mus musculus Heart
2 genes: APOE | NCOR1
1
22. paricalcitol cell proliferation arsenic trioxide [paricalcitol co-treated with arsenic trioxide] results in decreased cell proliferation Bone Marrow | Myeloid Cells | Cell Line, Tumor
9 genes: BCL2 | BCL2L1 | BMP4 | CRIP1 | IL1A | ITGA2 | NPY | TGFB1 | TNF
1
23. paricalcitol cell proliferation paricalcitol results in decreased cell proliferation 1: Homo sapiens U937 Cells
9 genes: BCL2 | BCL2L1 | BMP4 | CRIP1 | IL1A | ITGA2 | NPY | TGFB1 | TNF
1
24. paricalcitol monocyte differentiation arsenic trioxide [paricalcitol co-treated with arsenic trioxide] results in increased monocyte differentiation 1: Homo sapiens Bone Marrow | Myeloid Cells | Cell Line, Tumor
2 genes: BMP4 | PPARG
1
25. paricalcitol apoptotic process paricalcitol results in increased apoptotic process 1: Homo sapiens HL-60 Cells
11 genes: BCL2 | BCL2A1A | BCL2L1 | CD14 | IL1A | IL1B | IL24 | NR4A1 | PRKCA | TNF | TNFRSF11B
1
26. paricalcitol positive regulation of response to oxidative stress paricalcitol results in increased positive regulation of response to oxidative stress 1: Mus musculus Heart   1
27. paricalcitol cholesterol homeostasis paricalcitol affects cholesterol homeostasis 1: Mus musculus Heart
2 genes: APOE | NCOR1
1
28. paricalcitol monocyte differentiation arsenic trioxide [paricalcitol co-treated with arsenic trioxide] results in increased monocyte differentiation 1: Homo sapiens HL-60 Cells
2 genes: BMP4 | PPARG
1
29. paricalcitol positive regulation of response to oxidative stress Antioxidants [paricalcitol results in increased positive regulation of response to oxidative stress] which results in increased abundance of Antioxidants 1: Mus musculus Heart   1
30. paricalcitol apoptotic process arsenic trioxide [paricalcitol co-treated with arsenic trioxide] results in increased apoptotic process 1: Homo sapiens HL-60 Cells
11 genes: BCL2 | BCL2A1A | BCL2L1 | CD14 | IL1A | IL1B | IL24 | NR4A1 | PRKCA | TNF | TNFRSF11B
1
31. Ergocalciferols drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased metabolism of Ergocalciferols 1: Homo sapiens Placenta | Mitochondria   1
32. Ergocalciferols drug metabolic process 22-hydroxycholesterol [22-hydroxycholesterol results in decreased drug metabolic process] which results in decreased metabolism of Ergocalciferols 1: Bos taurus Adrenal Cortex | Mitochondria   1
33. Ergocalciferols drug metabolic process Ketoconazole [Ketoconazole results in decreased drug metabolic process] which results in decreased metabolism of and results in decreased hydroxylation of Ergocalciferols 1: Homo sapiens Keratinocytes | Cell Line   1
1–33 of 33 results.